BFM
MIST icon

Boothbay Fund Management’s Milestone Pharmaceuticals MIST Stock Holding History

Boothbay Fund Management’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$620K Buy
462,669
+293,994
+174% +$470K 0.01% 1367
2026
Q1 		$201K Buy
+168,675
New +$295K ﹤0.01% 1780
2025
Q1 		– Sell
-30,790
Closed -$72.7K – 1625
2024
Q4 		$72.7K Buy
30,790
+11
+0% +$19 ﹤0.01% 1323
2024
Q3 		$46.8K Hold
30,779
– – ﹤0.01% 1513
2024
Q2 		$40.6K Hold
30,779
– – ﹤0.01% 1421
2024
Q1 		$55.1K Buy
30,779
+3,191
+12% +$5.18K ﹤0.01% 1464
2023
Q4 		$46.1K Hold
27,588
– – ﹤0.01% 1533
2023
Q3 		$85.5K Buy
27,588
+2,412
+10% +$7.5K ﹤0.01% 1583
2023
Q2 		$71.8K Hold
25,176
– – ﹤0.01% 1652
2023
Q1 		$99.2K Hold
25,176
– – ﹤0.01% 1941
2022
Q4 		$99.7K Sell
25,176
-48,576
-66% -$256K ﹤0.01% 1787
2022
Q3 		$678K Sell
73,752
-58,749
-44% -$446K 0.02% 1079
2022
Q2 		$815K Sell
132,501
-51,697
-28% -$318K 0.02% 919
2022
Q1 		$1.18M Buy
184,198
+9,735
+6% +$60.8K 0.03% 815
2021
Q4 		$1.14M Hold
174,463
– – 0.03% 694
2021
Q3 		$996K Sell
174,463
-50,295
-22% -$284K 0.03% 762
2021
Q2 		$1.24M Buy
224,758
+16,426
+8% +$93.2K 0.04% 599
2021
Q1 		$1.21M Hold
208,332
– – 0.05% 508
2020
Q4 		$1.4M Buy
208,332
+9,624
+5% +$64.4K 0.05% 377
2020
Q3 		$1.46M Buy
198,708
+150,908
+316% +$1.08M 0.09% 318
2020
Q2 		$181K Buy
+47,800
New +$154K 0.01% 809

Other funds holding MIST

PCM
Pavaki Capital Management Pueblo, Colorado $287M AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
LPC
Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return

Boothbay Fund Management's MIST Position: Q2 2026 in Review

Boothbay Fund Management increased its Milestone Pharmaceuticals (MIST) stake by 174% in Q2 2026, buying an estimated $470K and bringing the position to 462,669 shares worth $620K. The position accounts for 0.01% of the portfolio, ranked #1367.

Boothbay Fund Management first reported a position in MIST in Q2 2020 and has held it in 21 quarters since. The position peaked at $1.46M in Q3 2020. 78 funds tracked by Wall St. Rank hold MIST as of Q2 2026.

  • Boothbay Fund Management held 462,669 shares of Milestone Pharmaceuticals worth $620K as of Q2 2026.
  • Boothbay Fund Management bought 293,994 Milestone Pharmaceuticals shares in Q2 2026, an estimated $470K.
  • Milestone Pharmaceuticals made up 0.01% of Boothbay Fund Management's portfolio in Q2 2026, its #1367 holding.
  • Boothbay Fund Management first reported a position in Milestone Pharmaceuticals in Q2 2020 and has held it in 21 quarters since.
  • Boothbay Fund Management's Milestone Pharmaceuticals position peaked at $1.46M in Q3 2020.
  • 78 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.